atorvastatin has been researched along with bradykinin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Q; Parker, RA; Tesfamariam, B | 1 |
| Cunha, FQ; Cunha, TM; Ferreira, SH; Parada, CA; Poole, S; Santodomingo-Garzón, T; Valério, DA; Verri, WA | 1 |
| Eatough, R; Harada-Shiba, M; Kamiya, C; Makino, H; Ogura, M; Perrone, G; Soran, H; Stefanutti, C; Yoshimatsu, J | 1 |
3 other study(ies) available for atorvastatin and bradykinin
| Article | Year |
|---|---|
Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
Topics: Animals; Aorta; Atorvastatin; Bradykinin; Calcimycin; Cells, Cultured; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Vitro Techniques; Lipids; Microscopy, Fluorescence; NAD; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxygen; Pyrroles; Rats; Rats, Sprague-Dawley; Rhodamines; Simvastatin; Subcellular Fractions; Superoxide Dismutase; Up-Regulation; Vasodilation | 2003 |
Atorvastatin inhibits inflammatory hypernociception.
Topics: Animals; Atorvastatin; Bradykinin; Cholesterol; Cytokines; Dinoprostone; Enzyme Inhibitors; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperalgesia; Inflammation; Interleukin-1; Lipopolysaccharides; Male; Mice; Nitric Oxide Synthase; Pain Measurement; Pyrroles; Skin | 2006 |
Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion.
Topics: Adolescent; Atorvastatin; Blood Component Removal; Bradykinin; Child; Child, Preschool; Decision Making; Female; Homozygote; Humans; Hyperlipoproteinemia Type II; Infant; Lipoproteins; Myocardial Infarction; Patient Compliance; Pregnancy; Pregnancy Complications, Cardiovascular; Treatment Outcome; Young Adult | 2016 |